Risk of drug use during pregnancy: master protocol for living systematic reviews and meta-analyses performed in the metaPreg project

[1] Boutron I(2020)Future of evidence ecosystem series: 1. introduction evidence synthesis ecosystem needs dramatic change J Clin Epidemiol 123 135-42

[2] Créquit P(2020)Challenges in meta-analyses with observational studies Evid Based Ment Health. 23 83-7

[3] Williams H(2013)Methodological challenges in using routinely collected health data to investigate long-term effects of medication use during pregnancy Ther Adv Drug Saf. 4 27-37

[4] Meerpohl J(2019)Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy Pharmacoepidemiol Drug Saf. 28 906-22

[5] Craig JC(2018)Making fair comparisons in pregnancy medication safety studies: an overview of advanced methods for confounding control Pharmacoepidemiol Drug Saf. 27 140-7

[6] Ravaud P(2018)An overview of meta-analysis for clinicians Korean J Intern Med. 33 277-83

[7] Metelli S(2022)A new taxonomy was developed for overlap across “overviews of systematic reviews”: a meta-research study of research waste Res Synth Methods. 13 315-29

[8] Chaimani A(2016)The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses: mass production of systematic reviews and meta-analyses Milbank Q. 94 485-514

[9] Grzeskowiak LE(2021)An epidemic of redundant meta-analyses J Thromb Haemost. 19 1299-306

[10] Gilbert AL(2021)Most published meta-analyses were made available within two years of protocol registration Eur J Integr Med. 44 195-7

[1] Boutron I(2020)Future of evidence ecosystem series: 1. introduction evidence synthesis ecosystem needs dramatic change J Clin Epidemiol 123 135-42

[2] Créquit P(2020)Challenges in meta-analyses with observational studies Evid Based Ment Health. 23 83-7

[3] Williams H(2013)Methodological challenges in using routinely collected health data to investigate long-term effects of medication use during pregnancy Ther Adv Drug Saf. 4 27-37

[4] Meerpohl J(2019)Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy Pharmacoepidemiol Drug Saf. 28 906-22

[5] Craig JC(2018)Making fair comparisons in pregnancy medication safety studies: an overview of advanced methods for confounding control Pharmacoepidemiol Drug Saf. 27 140-7

[6] Ravaud P(2018)An overview of meta-analysis for clinicians Korean J Intern Med. 33 277-83

[7] Metelli S(2022)A new taxonomy was developed for overlap across “overviews of systematic reviews”: a meta-research study of research waste Res Synth Methods. 13 315-29

[8] Chaimani A(2016)The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses: mass production of systematic reviews and meta-analyses Milbank Q. 94 485-514

[9] Grzeskowiak LE(2021)An epidemic of redundant meta-analyses J Thromb Haemost. 19 1299-306

[10] Gilbert AL(2021)Most published meta-analyses were made available within two years of protocol registration Eur J Integr Med. 44 195-7